ARTICLE | Top Story
CPMP recommends Fabry products
March 28, 2001 8:00 AM UTC
Europe's CPMP recommended approval of two enzyme replacement therapies to treat Fabry disease: Replagal agalsidase alfa from Transkaryotic Therapies (TKTX) and Fabrazyme agalsidase beta from Genzyme (...